Stage IV Pancreatic Cancer
Showing 26 - 50 of 79
Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Chicago (biological,
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- +3 more
- ipilimumab
- +2 more
-
Chicago, IllinoisNorthwestern University
Feb 24, 2020
Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,
Completed
- Pancreatic Adenocarcinoma
- +4 more
- Oxaliplatin
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in
Terminated
- Acinar Cell Adenocarcinoma of the Pancreas
- +2 more
- bortezomib
- +2 more
-
Houston, TexasMD Anderson Cancer Network
Oct 30, 2019
Stage IV Pancreatic Cancer Trial in Scottsdale, New Brunswick, Bethlehem (nab-paclitaxel, Cisplatin, gemcitabine)
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- vismodegib
- +6 more
-
Scottsdale, Arizona
- +2 more
Apr 4, 2019
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Australia, Singapore, United
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- saracatinib
- +5 more
-
Scottsdale, Arizona
- +8 more
Mar 20, 2019
Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +4 more
- 6,8-bis(benzylthio)octanoic acid
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Dec 26, 2018
Stage IV Pancreatic Cancer Trial in Russian Federation, United States (Gemcitabine, PEGPH20, Placebo)
Completed
- Stage IV Pancreatic Cancer
- Gemcitabine
- +2 more
-
Fayetteville, Arkansas
- +11 more
Oct 29, 2018
Stage IV Pancreatic Cancer Trial in Philadelphia (Ascorbic Acid)
Terminated
- Stage IV Pancreatic Cancer
- Ascorbic Acid
-
Philadelphia, PennsylvaniaThomas Jefferson University
Jul 30, 2018
Extrahepatic Bile Duct Cancer, Nausea, Vomiting Trial in Winston-Salem (drug, procedure, other)
Completed
- Extrahepatic Bile Duct Cancer
- +5 more
- aprepitant
- +8 more
-
Winston-Salem, North CarolinaWake Forest University Health Sciences
Jul 16, 2018
Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected
Completed
- Recurrent Melanoma
- +11 more
- siRNA-transfected peripheral blood mononuclear cells APN401
- laboratory biomarker analysis
-
Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
Jul 2, 2018
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (drug,
Completed
- Pancreatic Acinar Cell Carcinoma
- +3 more
- Carboplatin
- +3 more
-
Washington, District of Columbia
- +5 more
Feb 8, 2018
Pancreatic Carcinoma Non-resectable, Stage IV Pancreatic Cancer Trial in Goodyear (Gemcitabine, nab-Paclitaxel)
Terminated
- Pancreatic Carcinoma Non-resectable
- Stage IV Pancreatic Cancer
-
Goodyear, ArizonaWestern Regional Medical Center
Jan 11, 2018
Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, Gallbladder Carcinoma Trial in United States (Paclitaxel
Completed
- Adenocarcinoma of Unknown Primary
- +16 more
- Paclitaxel Albumin-Stabilized Nanoparticle Formulation
- +4 more
-
Chicago, Illinois
- +7 more
Dec 8, 2017
Adenocarcinoma of the Pancreas, Pancreatic Cancer, Recurrent Pancreatic Cancer Trial in Toronto (eribulin mesylate)
Completed
- Adenocarcinoma of the Pancreas
- +5 more
- eribulin mesylate
-
Toronto, Ontario, CanadaUniversity Health Network-Princess Margaret Hospital
Sep 19, 2017
Patient Derived Cancer Cell Lines in Identifying Molecular
Withdrawn
- Pancreatic Ductal Adenocarcinoma
- +6 more
- Laboratory Biomarker Analysis
- Cytology Specimen Collection Procedure
-
Philadelphia, PennsylvaniaThomas Jefferson University
Sep 5, 2017
Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer Trial in Ann Arbor (Gemcitabine Hydrochloride, Laboratory Biomarker
Completed
- Recurrent Pancreatic Carcinoma
- Stage IV Pancreatic Cancer
- Gemcitabine Hydrochloride
- +2 more
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
Aug 2, 2017
Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (drug,
Completed
- Duct Cell Adenocarcinoma of the Pancreas
- +2 more
- gemcitabine hydrochloride
- +3 more
-
Rochester, MinnesotaMayo Clinic
Mar 21, 2017
Colon Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Buffalo (Fluorouracil, Irinotecan
Withdrawn
- Colon Adenocarcinoma
- +16 more
- Fluorouracil
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 19, 2016
Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (Akt
Completed
- Pancreatic Acinar Cell Carcinoma
- +3 more
- Akt Inhibitor MK2206
- +3 more
-
Tucson, Arizona
- +533 more
Feb 10, 2016
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,
Completed
- Adenocarcinoma of the Colon
- +66 more
- cetuximab
- +2 more
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Sep 28, 2015
Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (vismodegib,
Completed
- Adenocarcinoma of the Pancreas
- +2 more
- vismodegib
- +2 more
-
Beverly Hills, California
- +25 more
Jul 20, 2015